Logo image of UTMD

UTAH MEDICAL PRODUCTS INC (UTMD) Stock Fundamental Analysis

NASDAQ:UTMD - Nasdaq - US9174881089 - Common Stock - Currency: USD

58.18  +1.74 (+3.08%)

Fundamental Rating

6

Taking everything into account, UTMD scores 6 out of 10 in our fundamental rating. UTMD was compared to 187 industry peers in the Health Care Equipment & Supplies industry. UTMD gets an excellent profitability rating and is at the same time showing great financial health properties. UTMD is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

UTMD had positive earnings in the past year.
UTMD had a positive operating cash flow in the past year.
In the past 5 years UTMD has always been profitable.
In the past 5 years UTMD always reported a positive cash flow from operatings.
UTMD Yearly Net Income VS EBIT VS OCF VS FCFUTMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

1.2 Ratios

The Return On Assets of UTMD (11.32%) is better than 93.58% of its industry peers.
UTMD's Return On Equity of 11.81% is amongst the best of the industry. UTMD outperforms 87.70% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.46%, UTMD belongs to the top of the industry, outperforming 90.37% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for UTMD is above the industry average of 7.91%.
Industry RankSector Rank
ROA 11.32%
ROE 11.81%
ROIC 9.46%
ROA(3y)12.3%
ROA(5y)11.87%
ROE(3y)13.06%
ROE(5y)12.7%
ROIC(3y)12.32%
ROIC(5y)12.29%
UTMD Yearly ROA, ROE, ROICUTMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 33.92%, UTMD belongs to the top of the industry, outperforming 97.86% of the companies in the same industry.
UTMD's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 33.23%, UTMD belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of UTMD has remained more or less at the same level.
UTMD has a Gross Margin of 59.03%. This is comparable to the rest of the industry: UTMD outperforms 58.29% of its industry peers.
UTMD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 33.23%
PM (TTM) 33.92%
GM 59.03%
OM growth 3Y-0.06%
OM growth 5Y0.46%
PM growth 3Y4%
PM growth 5Y1.55%
GM growth 3Y-2.17%
GM growth 5Y-1.24%
UTMD Yearly Profit, Operating, Gross MarginsUTMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

10

2. Health

2.1 Basic Checks

UTMD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
UTMD has less shares outstanding than it did 1 year ago.
The number of shares outstanding for UTMD has been reduced compared to 5 years ago.
There is no outstanding debt for UTMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
UTMD Yearly Shares OutstandingUTMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
UTMD Yearly Total Debt VS Total AssetsUTMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

UTMD has an Altman-Z score of 24.62. This indicates that UTMD is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 24.62, UTMD belongs to the best of the industry, outperforming 95.19% of the companies in the same industry.
UTMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 24.62
ROIC/WACC1.05
WACC8.99%
UTMD Yearly LT Debt VS Equity VS FCFUTMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 25.64 indicates that UTMD has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 25.64, UTMD belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 23.29 indicates that UTMD has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 23.29, UTMD belongs to the best of the industry, outperforming 99.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 25.64
Quick Ratio 23.29
UTMD Yearly Current Assets VS Current LiabilitesUTMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

UTMD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.50%.
The Earnings Per Share has been growing slightly by 0.16% on average over the past years.
The Revenue for UTMD has decreased by -18.57% in the past year. This is quite bad
UTMD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.70% yearly.
EPS 1Y (TTM)-13.5%
EPS 3Y-0.66%
EPS 5Y0.16%
EPS Q2Q%-27.33%
Revenue 1Y (TTM)-18.57%
Revenue growth 3Y-5.87%
Revenue growth 5Y-2.7%
Sales Q2Q%-25.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UTMD Yearly Revenue VS EstimatesUTMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.73, which indicates a correct valuation of UTMD.
Based on the Price/Earnings ratio, UTMD is valued cheaply inside the industry as 87.17% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.69, UTMD is valued a bit cheaper.
Industry RankSector Rank
PE 14.73
Fwd PE N/A
UTMD Price Earnings VS Forward Price EarningsUTMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UTMD is valued cheaply inside the industry as 96.79% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of UTMD indicates a rather cheap valuation: UTMD is cheaper than 93.58% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.95
EV/EBITDA 6.13
UTMD Per share dataUTMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The excellent profitability rating of UTMD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)94.88
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

UTMD has a Yearly Dividend Yield of 2.18%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.91, UTMD pays a better dividend. On top of this UTMD pays more dividend than 96.26% of the companies listed in the same industry.
UTMD's Dividend Yield is comparable with the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 2.18%

5.2 History

The dividend of UTMD has a limited annual growth rate of 1.95%.
UTMD has paid a dividend for at least 10 years, which is a reliable track record.
UTMD has decreased its dividend in the last 3 years.
Dividend Growth(5Y)1.95%
Div Incr Years2
Div Non Decr Years2
UTMD Yearly Dividends per shareUTMD Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

30.70% of the earnings are spent on dividend by UTMD. This is a low number and sustainable payout ratio.
UTMD's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP30.7%
EPS Next 2YN/A
EPS Next 3YN/A
UTMD Yearly Income VS Free CF VS DividendUTMD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M
UTMD Dividend Payout.UTMD Dividend Payout, showing the Payout Ratio.UTMD Dividend Payout.PayoutRetained Earnings

More info and screens

UTAH MEDICAL PRODUCTS INC

NASDAQ:UTMD (7/23/2025, 4:30:02 PM)

58.18

+1.74 (+3.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-24 2025-04-24
Earnings (Next)07-29 2025-07-29
Inst Owners70.84%
Inst Owner Change-0.08%
Ins Owners7.04%
Ins Owner Change0%
Market Cap189.09M
Analysts0
Price TargetN/A
Short Float %3.37%
Short Ratio6.19
Dividend
Industry RankSector Rank
Dividend Yield 2.18%
Yearly Dividend1.22
Dividend Growth(5Y)1.95%
DP30.7%
Div Incr Years2
Div Non Decr Years2
Ex-Date06-16 2025-06-16 (0.305)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.73
Fwd PE N/A
P/S 4.62
P/FCF 12.95
P/OCF 12.75
P/B 1.61
P/tB 1.87
EV/EBITDA 6.13
EPS(TTM)3.95
EY6.79%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.49
FCFY7.72%
OCF(TTM)4.56
OCFY7.84%
SpS12.59
BVpS36.13
TBVpS31.07
PEG (NY)N/A
PEG (5Y)94.88
Profitability
Industry RankSector Rank
ROA 11.32%
ROE 11.81%
ROCE 11.44%
ROIC 9.46%
ROICexc 31.39%
ROICexgc 58.06%
OM 33.23%
PM (TTM) 33.92%
GM 59.03%
FCFM 35.68%
ROA(3y)12.3%
ROA(5y)11.87%
ROE(3y)13.06%
ROE(5y)12.7%
ROIC(3y)12.32%
ROIC(5y)12.29%
ROICexc(3y)38.7%
ROICexc(5y)33.39%
ROICexgc(3y)78.49%
ROICexgc(5y)75.65%
ROCE(3y)14.9%
ROCE(5y)14.86%
ROICexcg growth 3Y-5.7%
ROICexcg growth 5Y-2.21%
ROICexc growth 3Y5.77%
ROICexc growth 5Y9.65%
OM growth 3Y-0.06%
OM growth 5Y0.46%
PM growth 3Y4%
PM growth 5Y1.55%
GM growth 3Y-2.17%
GM growth 5Y-1.24%
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 8.41%
Cap/Sales 0.57%
Interest Coverage 250
Cash Conversion 90.49%
Profit Quality 105.2%
Current Ratio 25.64
Quick Ratio 23.29
Altman-Z 24.62
F-Score6
WACC8.99%
ROIC/WACC1.05
Cap/Depr(3y)10.06%
Cap/Depr(5y)9.94%
Cap/Sales(3y)1.14%
Cap/Sales(5y)1.32%
Profit Quality(3y)119.58%
Profit Quality(5y)135.38%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.5%
EPS 3Y-0.66%
EPS 5Y0.16%
EPS Q2Q%-27.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.57%
Revenue growth 3Y-5.87%
Revenue growth 5Y-2.7%
Sales Q2Q%-25.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.01%
EBIT growth 3Y-5.93%
EBIT growth 5Y-2.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32.56%
FCF growth 3Y-10.92%
FCF growth 5YN/A
OCF growth 1Y-33.44%
OCF growth 3Y-11.23%
OCF growth 5Y-2.76%